XORTX Therapeutics Inc News, XORTX Therapeutics Inc Quote, XRTX Quote

XORTX Therapeutics Inc (NQ:XRTX) Delayed: 1.24 -0.18 (12.68%)

Prev. Close

$1.42

Today 6M 1Y 5Y

Open

$1.39

52 Wk High

$13.52

52 Wk Low

$8.94

Day High

$1.42

Day Low

$1.21

P/E

N/A

EPS

$-0.27

Volume

94,528

Friends, Peers and Foes (?): ANUA ANU (more...)

ALERTS | RSS

Oct 8, 2026 04:07 PM Form 6-K XORTX Therapeutics Inc. For: Oct 08
Oct 8, 2026 04:00 PM XORTX plans Health Canada application for gout drug XRx-026
Oct 8, 2026 04:00 PM XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
Sep 18, 2026 08:05 AM XORTX plans FDA IND filing for gout drug in Q4 2026
Sep 18, 2026 08:05 AM Form 6-K XORTX Therapeutics Inc. For: Sep 18
Sep 18, 2026 08:05 AM XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
Sep 10, 2026 04:18 PM Form 6-K XORTX Therapeutics Inc. For: Sep 10
Sep 10, 2026 04:07 PM XORTX begins manufacturing of gout drug candidate XORLO
Sep 10, 2026 04:05 PM XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
Sep 8, 2026 06:15 PM XORTX Re-Engages Investor Relations Program

Entities mentioned with XRTX

View All Entities